<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='../../ld1webpage.xsl'?>
<LOBBYINGDISCLOSURE1>
  <imported>N</imported>
  <pages>2</pages>
  <regType>2</regType>
  <organizationName>Venn Strategies</organizationName>
  <prefix>
  </prefix>
  <firstName>
  </firstName>
  <lastName>
  </lastName>
  <address1>1341 G Street NW, 6th Floor</address1>
  <address2>
  </address2>
  <city>WASHINGTON</city>
  <state>DC</state>
  <zip>20005</zip>
  <zipext>2000</zipext>
  <country>USA</country>
  <principal_city>
  </principal_city>
  <principal_state>
  </principal_state>
  <principal_zip>
  </principal_zip>
  <principal_zipext>
  </principal_zipext>
  <principal_country>
  </principal_country>
  <contactIntlPhone>
  </contactIntlPhone>
  <registrantGeneralDescription>Political and public affairs firm</registrantGeneralDescription>
  <selfSelect>N</selfSelect>
  <clientName>Voices for Non-Opioid Choices</clientName>
  <clientAddress>1341 G Street NW, 6th Floor</clientAddress>
  <clientCity>WASHINGTON</clientCity>
  <clientState>DC</clientState>
  <clientZip>20005</clientZip>
  <clientZipExt>
  </clientZipExt>
  <clientCountry>USA</clientCountry>
  <prinClientCity>
  </prinClientCity>
  <prinClientState>
  </prinClientState>
  <prinClientZip>
  </prinClientZip>
  <prinClientZipExt>
  </prinClientZipExt>
  <prinClientCountry>
  </prinClientCountry>
  <clientGeneralDescription>Advocacy Association</clientGeneralDescription>
  <senateID>65191</senateID>
  <houseID>355790116</houseID>
  <lobbyists>
    <lobbyist>
      <lobbyistFirstName>Tyler</lobbyistFirstName>
      <lobbyistLastName>Roberts</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>Lead Staff Advisor on health policy, tax trade and financial service matters for Senator Dan Sullivan (R-AK), Staff Assistant for Congressman Jeff Fortenberry (R-NE), Research Assistant for Congressman Joe Barton (R-TX) and Roy Blunt (R-MO).</coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>Shanta</lobbyistFirstName>
      <lobbyistLastName>Whitaker</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>Claire</lobbyistFirstName>
      <lobbyistLastName>Badger</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>U.S. Senate, Office of the Democratic Leader, Democratic Steering and Outreach Committee</coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>Kelly</lobbyistFirstName>
      <lobbyistLastName>Ferguson</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>Chris</lobbyistFirstName>
      <lobbyistLastName>Fox</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>Emilia</lobbyistFirstName>
      <lobbyistLastName>DiSanto</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>Deputy Inspector General-US Department of State; Chief of Staff - Federal Housing Finance Agency Office of Inspector General; Chief Investigative Counsel and Special Counsel - U.S. Senate Committee on Finance</coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
  </lobbyists>
  <alis>
    <ali_Code>HCR</ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
  </alis>
  <convictionDisclosure>
    <convictionDisclosureIndicator>N</convictionDisclosureIndicator>
    <convictions>
    </convictions>
  </convictionDisclosure>
  <specific_issues>Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.</specific_issues>
  <affiliatedUrl>
  </affiliatedUrl>
  <affiliatedOrgs>
    <affiliatedOrg>
      <affiliatedOrgName>Pacira Pharmaceuticals, Inc.</affiliatedOrgName>
      <affiliatedOrgAddress>5 Sylvan Way</affiliatedOrgAddress>
      <affiliatedOrgCity>Parsippany</affiliatedOrgCity>
      <affiliatedOrgState>NJ</affiliatedOrgState>
      <affiliatedOrgZip>07054</affiliatedOrgZip>
      <affiliatedOrgCountry>USA</affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
    <affiliatedOrg>
      <affiliatedOrgName>
      </affiliatedOrgName>
      <affiliatedOrgAddress>
      </affiliatedOrgAddress>
      <affiliatedOrgCity>
      </affiliatedOrgCity>
      <affiliatedOrgState>
      </affiliatedOrgState>
      <affiliatedOrgZip>
      </affiliatedOrgZip>
      <affiliatedOrgCountry>
      </affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
    <affiliatedOrg>
      <affiliatedOrgName>
      </affiliatedOrgName>
      <affiliatedOrgAddress>
      </affiliatedOrgAddress>
      <affiliatedOrgCity>
      </affiliatedOrgCity>
      <affiliatedOrgState>
      </affiliatedOrgState>
      <affiliatedOrgZip>
      </affiliatedOrgZip>
      <affiliatedOrgCountry>
      </affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
  </affiliatedOrgs>
  <foreignEntities>
    <foreignEntity>
      <name>
      </name>
      <address>
      </address>
      <city>
      </city>
      <state>
      </state>
      <country>
      </country>
      <prinCity>
      </prinCity>
      <prinState>
      </prinState>
      <prinCountry>
      </prinCountry>
      <contribution>
      </contribution>
      <ownership_Percentage>
      </ownership_Percentage>
    </foreignEntity>
    <foreignEntity>
      <name>
      </name>
      <address>
      </address>
      <city>
      </city>
      <state>
      </state>
      <country>
      </country>
      <prinCity>
      </prinCity>
      <prinState>
      </prinState>
      <prinCountry>
      </prinCountry>
      <contribution>
      </contribution>
      <ownership_Percentage>
      </ownership_Percentage>
    </foreignEntity>
  </foreignEntities>
  <reportYear>2019</reportYear>
  <reportType>RR</reportType>
  <effectiveDate>4/1/2019</effectiveDate>
  <printedName>Renee Yevette Carter-White</printedName>
  <signedDate>4/12/2019 10:46:54 AM</signedDate>
</LOBBYINGDISCLOSURE1>